Relative Biological Effectiveness
"Relative Biological Effectiveness" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ratio of radiation dosages required to produce identical change based on a formula comparing other types of radiation with that of gamma or roentgen rays.
|Relative Biological Effectiveness
- Relative Biological Effectiveness
- Effectiveness, Biological Relative
- Biological Relative Effectiveness
- Effectiveness, Biologic Relative
- Biologic Relative Effectiveness
- Relative Effectiveness, Biologic
- Relative Biologic Effectiveness
- Biologic Effectiveness, Relative
- Effectiveness, Relative Biologic
- Biological Effectiveness, Relative
- Effectiveness, Relative Biological
Below are MeSH descriptors whose meaning is more general than "Relative Biological Effectiveness".
Below are MeSH descriptors whose meaning is more specific than "Relative Biological Effectiveness".
This graph shows the total number of publications written about "Relative Biological Effectiveness" by people in this website by year, and whether "Relative Biological Effectiveness" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Relative Biological Effectiveness" by people in Profiles.
Hoel DG, Carnes BA. Cardiovascular effects of fission neutron or 60Co ? exposure in the B6CF1 mouse. Int J Radiat Biol. 2017 06; 93(6):563-568.
Schmitt JD, Warren GW, Wang IZ. Potential increase in biological effectiveness from field timing optimization for stereotactic body radiation therapy. Med Phys. 2012 Jun; 39(6):2956-63.
Priest ND, Hoel D. Determining the relative toxicity and RBE of internal emitters in animals. Health Phys. 2010 Sep; 99(3):367-70.
Stovall M, Smith SA, Langholz BM, Boice JD, Shore RE, Andersson M, Buchholz TA, Capanu M, Bernstein L, Lynch CF, Malone KE, Anton-Culver H, Haile RW, Rosenstein BS, Reiner AS, Thomas DC, Bernstein JL. Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys. 2008 Nov 15; 72(4):1021-30.
Brem MH, Zamani AA, Riva R, Zou KH, Rumboldt Z, Hennig FF, Kikinis R, Norbash AM, Schoepf UJ. Multidetector CT of the paranasal sinus: potential for radiation dose reduction. Radiology. 2007 Jun; 243(3):847-52.
Panzegrau B, Gordon L, Goudy GH. Outpatient therapeutic 131I for thyroid cancer. J Nucl Med Technol. 2005 Mar; 33(1):28-30.
Dragun AE, Aguero EG, Harmon JF, Harper JL, Jenrette JM. Chest wall dose in MammoSite breast brachytherapy: radiobiologic estimations of late complication risk based on dose-volume considerations. Brachytherapy. 2005; 4(4):259-63.
Baker GS, Hoel DG. Corrections in the atomic bomb data to examine low dose risk. Health Phys. 2003 Dec; 85(6):709-20.